DE GIORGI, UGO FEDERICO FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 797
EU - Europa 240
AS - Asia 122
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.161
Nazione #
US - Stati Uniti d'America 797
PL - Polonia 104
IT - Italia 58
CN - Cina 56
DE - Germania 22
SG - Singapore 21
UA - Ucraina 20
VN - Vietnam 20
GB - Regno Unito 18
TR - Turchia 17
ID - Indonesia 8
SE - Svezia 7
RU - Federazione Russa 5
FR - Francia 2
AT - Austria 1
BR - Brasile 1
EU - Europa 1
FI - Finlandia 1
MK - Macedonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.161
Città #
Fairfield 142
Warsaw 104
Woodbridge 84
Chandler 76
Ashburn 74
Houston 70
Cambridge 46
Seattle 45
Wilmington 39
Jacksonville 25
Dearborn 23
Princeton 23
Milan 21
Dong Ket 20
Ann Arbor 18
Izmir 16
Singapore 13
Beijing 12
San Diego 12
Ferrara 10
Jakarta 8
Nanjing 8
Shanghai 7
Nanchang 6
Hebei 5
Bremen 4
Addison 3
Boardman 3
Bologna 3
Chicago 3
Jiaxing 3
London 3
Shenyang 3
Calderara di Reno 2
Cesena 2
Forlimpopoli 2
Giovinazzo 2
Hefei 2
Kunming 2
Norwalk 2
Araucária 1
Bratislava 1
Changsha 1
Chongqing 1
Edinburgh 1
Falls Church 1
Imola 1
Jinan 1
Jinhua 1
Kilburn 1
Lanzhou 1
Leawood 1
Limeil-brévannes 1
Melito Di Napoli 1
Monterotondo 1
Mountain View 1
Orange 1
Phoenix 1
Portomaggiore 1
Prescot 1
Prilep 1
Redmond 1
Redwood City 1
Santa Maria Capua Vetere 1
Segrate 1
Taiyuan 1
Tianjin 1
Vicenza 1
Vienna 1
Wandsworth 1
Washington 1
Wuhan 1
Totale 978
Nome #
Early use of abiraterone and radium-223 in metastatic prostate cancer 157
18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide 148
PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis 117
68 Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients 111
[177 Lu]-PSMA-617 for targeted prostate cancer treatment: a magic bullet? 97
68Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer 74
Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer 71
Testicular Microlithiasis and Testicular Germ Cell Tumours: a seven year retrospective study 55
Erratum to: 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5] 55
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer 47
Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review 44
Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients 40
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide 36
CAR-T cell therapy: A potential new strategy against prostate cancer 35
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell transplantation for high-risk breast cancer: results from the italian National Registry 30
Targeted radioactive therapy for prostate cancer 21
Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial 19
Spotlight on PSMA as a new theranostic biomarker for bladder cancer 19
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients 18
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome 17
Post-traumatic stress symptoms in long-term disease-free cancer survivors and their family caregivers 15
Totale 1.226
Categoria #
all - tutte 8.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020319 39 12 14 41 28 38 37 33 35 19 14 9
2020/2021290 10 9 10 9 26 67 21 35 17 41 17 28
2021/2022169 13 8 4 3 4 12 18 35 8 14 15 35
2022/2023187 22 5 23 6 26 30 18 11 21 1 17 7
2023/202473 15 5 5 3 7 3 1 5 0 1 3 25
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 1.226